Listing 1 - 10 of 12 | << page >> |
Sort by
|
Choose an application
General considerations in the evaluation and treatment of poisoning / Steven B. Bird -- Acetaminophen / Steven B. Bird -- Alcohols and glycols / Steven B. Bird -- Antiarrhythmic agents / D. Eric Brush -- Anticholinergic poisoning / Ivan E. Liang -- Anticonvulsants / Ivan E. Liang -- Antidepressant poisoning / Eric Brush -- Antihypertensive agents / Ivan E. Liang -- Antimicrobial agents / D. Eric Brush -- Antipsychotic agents / Steven B. Bird -- [Beta]-blocker poisoning / Steven B. Bird -- Calcium channel blockers / Steven B. Bird -- Cholinergic agents / Steven B. Bird -- Cocaine poisoning / Ivan E. Liang -- Corrosive ingestions / Steven B. Bird --
Poisoning --- Drugs --- Poisoning --- Drug Overdose --- Toxicology
Choose an application
Poisons --- Hazardous Substances --- Antidotes --- Drug Overdose
Choose an application
Les développements technologiques dans le domaine médical ont entraîné un nouveau risque de dérive dans la pratique de chaque médecin : la surmédicalisation. Il est primordial pour les médecins généralistes, acteurs de première ligne et responsables de la prise en charge globale des patients, d’être attentifs et bien informés pour pouvoir utiliser à bon escient la balance bénéfice /risques de leurs prescriptions, en tenant compte du patient et de ses spécificités. Ce travail de fin d’études a détaillé la création, par une équipe de médecins généralistes, d’une « cellule » spécifiquement dédiée à la rédaction et à la publication, sur la plateforme interactive du site internet de la SSMG, de fiches destinées à fournir des informations sur différents sujets de prévention quaternaire. Ce thème est particulièrement intéressant et d’actualité vu l’importance de ce type de prévention qui consiste à éviter l’excès de diagnostics inutiles et la surmédicalisation des patients. Pour faire connaître la « cellule de prévention quaternaire », nous avons rédigé et publié plusieurs articles sur différents supports (presse écrite, Internet, etc.). Nous l’avons également présentée lors d’un groupe local d’évaluation médicale, et lors du séminaire loco-régionaux. Ce travail pourrait constituer la première étape pour amener les médecins généralistes à une nouvelle réflexion concernant la prévention quaternaire. De nombreuses améliorations sont en encore en chantier pour le site, comme augmenter l’interactivité avec les lecteurs. Un autre but est de recruter de futurs assistants pour rédiger de nouvelles fiches et permettre d’étendre notre cellule.
Internet --- Patient Portals --- Medical Overuse --- Medical Overuse --- Drug Overdose
Choose an application
Drug abuse --- Substance abuse --- Drug Overdose. --- Substance-Related Disorders --- epidemiology. --- Drug Abuse Warning Network. --- United States.
Choose an application
Drugs, sex and a pack of unscrupulous men circling, circling - it was always going to get ugly but no-one foresaw the tragic death of a young woman.
Australians --- Drugs --- Drug overdose --- Overdosage of drugs --- Overdose of drugs --- Poisoning --- Medication errors --- Aussies --- Ethnology --- Overdose. --- Overdosage --- Dosage --- Brimble, Dianne. --- Accidental poisoning --- Trials --- Victims of crimes --- Wrongful death
Choose an application
This book provides an in-depth look at clinical and public health approaches to this epidemic from both psychiatric and medical perspectives and gives mental health professionals the big picture necessary to understand the epidemic.
United States --- Opioid-Related Disorders --- Analgesics, Opioid --- Naloxone --- Drug Overdose --- adverse effects --- therapeutic use --- Opioid abuse --- Opioid abuse. --- Drugs --- Treatment. --- Overdose.
Choose an application
"According to the CDC, between 1999 and 2017, more than 700,000 Americans died as a result of drug overdose. In 2017, the number of overdose deaths involving opioids (including prescription opioids and illegal opioids such as heroin and illicitly manufactured fentanyl) was 6 times higher than in 1999. The news is rife with stories surrounding the opioid crisis-from settlements with drug companies, to effective treatment options-even the resistance among museums to accept donations from the Sackler family (which built its fortune on pharmaceutical sales of OxyContin). What was once perceived as a marginal problem has now entered the mainstream, and this book looks at its rise. Nancy Campbell, professor and department head in STS at RPI, traces the history of overdose and overdose prevention. Her research centers on how ideas about drugs and drug addiction have changed over time. She wants to know what we actually know about drug addiction, and how we know it. Why do we have the drug policies that we do? And why do we consider some drugs to cause social problems, and others to solve them. Most importantly, Campbell asks, why did it take tens of thousands of opioid-related overdose deaths annually before a movement rose up to put this technology into the hands of those who needed it most? The book centers around the political contexts within which overdose and overdose prevention became problems that could be solved with a technological fix. As is the case with all such fixes, the social, political, and economic terrain within which they are implemented matter for their success. The book provides an accessible history of how naloxone works in the United States and the United Kingdom, both places that have experienced exponential increases in overdose deaths during the early 21st century (albeit at different scales). As a historical book, it interweaves the story of naloxone's predecessor, nalorphine, with the story of the pharmacological dynamics of the so-called narcotic antagonists. All of the technical terms involved-agonists, antagonists, opioids, and opiates, are clearly defined in the introduction, and in punchy, non-technical prose at that. But it is the story of the protagonists-the people of naloxone-that matters most to Campbell. The protagonists of these social and scientific movements have broadened naloxone access, changing law, medicine, and society-and have saved countless lives. This book, then, traces the story of a single molecule through its multiple social lives, from the enclaves of its past into the wider worlds of its present. We're starting to see a number of books on the market about this epidemic, but what Campbell is doing here is looking specifically at the social movement (the harm reduction movement) aimed at preventing preventable deaths, and the role Naloxone has played in those efforts. Campbell concludes on a powerful note, pointing out that even though we have a technology that can help stop-in-its tracks sudden death, until we start really examining the root causes and circumstances surrounding the rise in opioid abuse and uptake in the first place, this problem is going nowhere"--
Drugs --- Naloxone. --- Overdose. --- Narcotics --- Overdose --- Alkaloids --- Narcotic antagonists --- Drug overdose --- Overdosage of drugs --- Overdose of drugs --- Poisoning --- Medication errors --- Overdosage --- Dosage --- United States --- United Kingdom --- Great Britain --- Isle of Man
Choose an application
""Grounded equally in solid clinical practice and uniquely relevant research, and tragically leavened by the personal bereavement of two of the book's authors, Devastating Losses sheds new and compassionate light on the experience of a child's death to traumatic causes."". Robert A. Neimeyer , PhD. Editor, Death Studies. ""This volume is a pioneering and long overdue work, a study not only of grieving parents who lost a child to suicide but also of parents whose children succumbed to drug overdoses. The authors have done a masterful job of blending their quantitative research findings and the
Children --- Parents --- Bereavement --- Drugs --- Suicide victims --- Suicides --- Victims of suicide --- Dead --- Victims of crimes --- Drug overdose --- Overdosage of drugs --- Overdose of drugs --- Poisoning --- Medication errors --- Mourning --- Death --- Psychological aspects. --- Psychology. --- Overdose. --- Family relationships. --- Overdosage --- Dosage --- Psychological aspects
Choose an application
Serait-ce la fin du rêve américain ? L'espérance de vie aux Etats-Unis a récemment baissé : du jamais-vu en Occident depuis 1918. Durant les deux dernières décennies, le nombre des suicides ou des décès dus à l'alcoolisme et à la consommation de drogues n'a cessé d'augmenter. Anne Case et le prix Nobel d'économie Angus Deaton ont été les premiers à tirer la sonnette d'alarme face à ce phénomène qui affecte principalement la classe ouvrière blanche. Ils dressent dans cet ouvrage le portrait d'une Amérique dont le système économique et social conduit à l'enrichissement toujours plus important des riches, tandis qu'il abandonne les non-diplômés, autrefois portés par l'American Dream et désormais condamnés au désespoir. Les auteurs livrent une analyse puissante de la façon dont les excès du capitalisme détruisent les classes populaires américaines et ruinent tous leurs espoirs. Ils proposent également des pistes pour enrayer cette spirale mortifère.
Premature death --- Public health --- Life expectancy --- Capitalism --- Suicide --- Socioeconomic Factors. --- Drug Overdose --- Capitalism. --- Educational Status. --- Politics. --- Social aspects --- economics. --- United States --- Social conditions --- Socioeconomic Factors --- Educational Status --- Politics --- economics --- Espérance de vie --- Décès --- Conditions sociales --- Capitalisme --- Causes --- Premature death - United States --- Public health - United States --- Life expectancy - United States --- Capitalism - Social aspects - United States --- Suicide - economics --- Drug Overdose - economics --- United States - Social conditions - 21st century
Choose an application
Nonclinical Assessment of Abuse Potential for New Pharmaceuticals offers a complete reference on the current international regulatory guidelines and details best practice methodology for the three standard animal models used to evaluate abuse potential: physical dependence, self-administration and drug discrimination. This book also includes chapters on alternative models and examples of when you should use these alternatives. Case histories are provided at the end of the book to show how the data generated from the animal models play a pivitol role in the submission package for a new drug. By incorporating all of this information into one book, Nonclinical Assessment of Abuse Potential for New Pharmaceuticals is your single resource for everything you need to know to understand and implement the assessment of abuse liability. Provides a consolidated overview of the complex regulatory landscape Offers best practice methodology for conducting animal studies, including selection of doses and positive control agents that will help you improve your own abuse potential studies Includes real-life examples to illustrate how nonclinical data fit into the submission strategy.
Drug abuse. --- Drugs. --- Psychopharmacology. --- Drug Evaluation, Preclinical --- Models, Animal --- Substance-Related Disorders --- Investigative Techniques --- Mental Disorders --- Drug Discovery --- Diseases --- Evaluation Studies as Topic --- Psychiatry and Psychology --- Analytical, Diagnostic and Therapeutic Techniques and Equipment --- Substance Abuse --- Social Welfare & Social Work --- Social Sciences --- Drugs --- Opioids --- Overdose. --- Opium-like agents --- Analgesics --- Narcotics --- Opium --- Drug overdose --- Overdosage of drugs --- Overdose of drugs --- Poisoning --- Medication errors --- Drug use --- Substance abuse --- Overdosage --- Dosage
Listing 1 - 10 of 12 | << page >> |
Sort by
|